Market Research Report

Global Plasma Fractionation Market Report By Product (Albumin, Immunoglobulins, Coagulation Factor Concentrates, and Others), Application (Neurology, Hematology, Immunology, Critical Care, and Others), By End-User (Hospitals and Clinics, Clinical Research Laboratories And Academic Institutes), And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

ID:VMR11210047
March 2022
Report Formats: Electronic (PDF), MS EXCEL

The growth of the plasma fractionation market can be attributed to the factors such as a rise in the use of prophylactic treatment for immune & bleeding diseases and increased diagnosis rate worldwide. Ongoing growth in geriatric population and increasing use of the alpha-1-antitrypsin and immunoglobulin for various chronic diseases is likely to contribute to the growth of the global plasma fractionation market. Additionally, the rising incidence of the immunological and neurological diseases worldwide along with the increasing use of intravenous immunoglobulin in various therapeutic areas are boosting the growth of the global plasma fractionation market.

According to the Value Market Research, the Global Plasma Fractionation Market is estimated to grow at CAGR 7% from USD 19,875.5 MN in 2017 and reach USD 31,710.5 MN by 2024.
 
IMMUNOGLOBINS TO GAIN THE MOMENTUM
Immunoglobins product segment is the leading segment in 2017 owing to the growing incidence of chronic inflammatory demyelinating polyneuropathy and hypogammaglobulinemia disease coupled with a rise in the use of immunoglobulins to treat Guillain-Barre syndrome, inflammatory myopathies, and specific antibody deficiency disorder. By end of 2024, Immunoglobins is expected to reach USD 14,130.7 MN. In addition, the geriatric population and the emergence of advanced technologies, and enhanced purification techniques are the other key factors that support the growth of the segment. 
 
IMMUNOLOGY EMERGED AS HIGHLY PREFERRED APPLICATION AREA
Immunology is the dominating segment owing to the rising prevalence of immunodeficient disorder across the globe. Immunoglobulin is the most common protein used in blood fraction. Immunoglobulins, also known as antibodies, are glycoprotein molecules released by plasma cells (white blood cells). Basically, they act as a critical part of the immune response by specifically identifying and binding to specific antigens, such as bacteria or viruses, and supporting in their destruction. The high growth of this segment can be attributed to the increasing adoption of plasma products in the treatment of various immunological, neurological, and bleeding disorders.

HOSPITAL & CLINICS TO LEAD THE SEGMENT
The hospitals & clinics end-user segment is dominating in 2017, owing to the increasing adoption of plasma products in the treatment of various immunological, neurological, and bleeding disorders across hospital & clinics. Also, a growing number of the hospital along with an increase in healthcare expenditure is likely to push the growth of the segment uphill. Additionally, owing to the large patient pool treated in hospitals; expansion of hospitals & clinics across the globe along with the increasing number of collaborations between the manufacturers of plasma products and hospitals are again expected to propel the market of plasma fractionation.
 
NORTH AMERICA EMERGED AS THE LARGEST REGION IN THE GLOBAL MARKET FOR PLASMA FRACTIONATION
From the geographical perspective, in 2017, North America held the largest market share in the global plasma fractionation market due to increased use of immunoglobulin in the treatment of neurological diseases coupled with the use of the prophylaxis treatments to diagnosed patients. Moreover, increasing number of hemophilic patients in North America is also expected to boost the market growth in the region.
 
MAJOR COMPETITORS IN MARKET
Baxter International Inc., CSL Limited, Grifols, S.A., Octapharma AG, Bio Products Laboratory Ltd., Kedrion S.P.A., Shire Plc., Shanghai Raas, Hualan Biological Engineering Inc., Biotest AG, China Biologic Products Holdings, Inc., The LFB Group, Sanquin, Japan Blood Products Organization, and Green Cross Corp.

As per this study the global plasma fractionation market was valued at USD 25.58 MN (by revenue) in 2021 and is anticipated to reach USD 42.44 MN by 2028 with a CAGR of 7.5%.

Plasma fractionation is a process of extracting various components of blood-derived plasma. It acts as nature’s raw material which is used in dozens of life-saving treatments and medications. The process of plasma fractionation is used to treat protein deficiency disorders in the healthcare sector. The major function of plasma fractionation is to remove or inactivate the virus and prions. Plasma contains various proteins including immunoglobulins, albumin, and clotting proteins such as fibrinogen. Among these albumin constitutes about 60% of the total protein in plasma and is present at concentrations between 35 and 55 mg/ml. It is the key factor responsible to the osmotic pressure of the blood and it functions as a carrier molecule for molecules with low water solubilities such as lipid-soluble hormones, pharmaceutical compounds, enzymes, metal ions, and fatty acids.
 
Market Dynamics
 
Ongoing growth in geriatric population and rising prevalence’s of the immunological and neurological diseases coupled with increasing use of intravenous immunoglobulin in various therapeutic areas are likely to boost the market growth.  In addition, increasing use of the alpha-1-antitrypsin and immunoglobulin for various chronic diseases is further adding impetus growth of the global plasma fractionation market. However, expensive treatment and strict governmental policy are likely to limit the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of plasma fractionation.
 
Market Segmentation
 
The broad plasma fractionation market has been sub-grouped into product, application and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Product
  • Albumin
  • Immunoglobulins
  • Coagulation Factor Concentrates
  • Others
 
By Application
  • Neurology
  • Hematology
  • Immunology
  • Critical Care
  • Others
 
By End-User
  • Hospitals and Clinics
  • Clinical Research Laboratories
  • Academic Institutes
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for plasma fractionation in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Global Plasma Fractionation Market Share by Region (Representative Graph)
 
Global Plasma Fractionation Market Share
 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the plasma fractionation market include Baxter International Inc., CSL Limited, Grifols, S.A., Octapharma AG, Bio Products Laboratory Ltd., Kedrion S.P.A., Shire Plc., Shanghai Raas, Hualan Biological Engineering Inc., Biotest AG, China Biologic Products Holdings, Inc., The LFB Group, Sanquin, Japan Blood Products Organization and Green Cross Corp. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Frequently Asked Questions (FAQs) about this Report

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . PLASMA FRACTIONATION – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 Market Attractiveness Analysis By Product
           3.7.2 Market Attractiveness Analysis By Application
           3.7.3 Market Attractiveness Analysis By End-User
           3.7.4 Market Attractiveness Analysis By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic 
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL PLASMA FRACTIONATION MARKET ANALYSIS BY PRODUCT
       6.1 Overview by Product
       6.2 Historical and Forecast Data
       6.3 Analysis by Product
       6.4 Albumin Historic and Forecast Sales by Regions
       6.5 Immunoglobulins Historic and Forecast Sales by Regions
       6.6 Coagulation Factor Concentrates Historic and Forecast Sales by Regions
       6.7 Others Historic and Forecast Sales by Regions
 
7 . GLOBAL PLASMA FRACTIONATION MARKET ANALYSIS BY APPLICATION
       7.1 Overview by Application
       7.2 Historical and Forecast Data
       7.3 Analysis by Application
       7.4 Neurology Historic and Forecast Sales by Regions
       7.5 Hematology Historic and Forecast Sales by Regions
       7.6 Immunology Historic and Forecast Sales by Regions
       7.7 Critical Care Historic and Forecast Sales by Regions
       7.8 Others Historic and Forecast Sales by Regions
 
8 . GLOBAL PLASMA FRACTIONATION MARKET SALES ANALYSIS BY END-USER
       8.1 Overview by End-User
       8.2 Historical and Forecast Data
       8.3 Analysis by End-User
       8.4 Hospitals And Clinics Historic and Forecast Sales by Regions
       8.5 Clinical Research Laboratories Historic and Forecast Sales by Regions
       8.6 Academic Institutes Historic and Forecast Sales by Regions
 
9 . GLOBAL PLASMA FRACTIONATION MARKET SALES ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook Sales Analysis
       9.2. Introduction Sales Analysis
       9.3. North America Sales Analysis
           9.3.1. Overview, Historic and Forecast Sales Analysis
           9.3.2. North America By Segment Sales Analysis
           9.3.3. North America By Country Sales Analysis
           9.3.4. United State Sales Analysis
           9.3.5. Canada Sales Analysis
           9.3.6. Mexico Sales Analysis
       9.4. Europe Sales Analysis
           9.4.1. Overview, Historic and Forecast Sales Analysis
           9.4.2. Europe by Segment Sales Analysis
           9.4.3. Europe by Country Sales Analysis
           9.4.4. United Kingdom Sales Analysis
           9.4.5. France Sales Analysis
           9.4.6. Germany Sales Analysis
           9.4.7. Italy Sales Analysis
           9.4.8. Russia Sales Analysis
           9.4.9. Rest Of Europe Sales Analysis
       9.5. Asia Pacific Sales Analysis
           9.5.1. Overview, Historic and Forecast Sales Analysis
           9.5.2. Asia Pacific by Segment Sales Analysis
           9.5.3. Asia Pacific by Country Sales Analysis
           9.5.4. China Sales Analysis
           9.5.5. India Sales Analysis
           9.5.6. Japan Sales Analysis
           9.5.7. South Korea Sales Analysis
           9.5.8. Australia Sales Analysis
           9.5.9. Rest Of Asia Pacific Sales Analysis
       9.6. Latin America Sales Analysis
           9.6.1. Overview, Historic and Forecast Sales Analysis
           9.6.2. Latin America by Segment Sales Analysis
           9.6.3. Latin America by Country Sales Analysis
           9.6.4. Brazil Sales Analysis
           9.6.5. Argentina Sales Analysis
           9.6.6. Peru Sales Analysis
           9.6.7. Chile Sales Analysis
           9.6.8. Rest of Latin America Sales Analysis
       9.7. Middle East & Africa Sales Analysis
           9.7.1. Overview, Historic and Forecast Sales Analysis
           9.7.2. Middle East & Africa by Segment Sales Analysis
           9.7.3. Middle East & Africa by Country Sales Analysis
           9.7.4. Saudi Arabia Sales Analysis
           9.7.5. UAE Sales Analysis
           9.7.6. Israel Sales Analysis
           9.7.7. South Africa Sales Analysis
           9.7.8. Rest Of Middle East And Africa Sales Analysis
 
10 . COMPETITIVE LANDSCAPE OF THE PLASMA FRACTIONATION COMPANIES
       10.1. Plasma Fractionation Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF PLASMA FRACTIONATION INDUSTRY
       11.1. Top 10  Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Baxter International Inc.
           11.3.1. Company Overview
           11.3.2. Company Revenue
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. CSL Limited
           11.4.1. Company Overview
           11.4.2. Company Revenue
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Grifols
           11.5.1. Company Overview
           11.5.2. Company Revenue
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. S.A.
           11.6.1. Company Overview
           11.6.2. Company Revenue
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Octapharma AG
           11.7.1. Company Overview
           11.7.2. Company Revenue
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Bio Products Laboratory Ltd.
           11.8.1. Company Overview
           11.8.2. Company Revenue
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Kedrion S.P.A.
           11.9.1. Company Overview
           11.9.2. Company Revenue
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. Shire Plc.
           11.10.1. Company Overview
           11.10.2. Company Revenue
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Shanghai Raas
           11.11.1. Company Overview
           11.11.2. Company Revenue
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Hualan Biological Engineering Inc.
           11.12.1. Company Overview
           11.12.2. Company Revenue
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. Biotest AG
           11.13.1. Company Overview
           11.13.2. Company Revenue
           11.13.3. Products
           11.13.4. Recent Developments
       11.14. China Biologic Products Holdings Inc.
           11.14.1. Company Overview
           11.14.2. Company Revenue
           11.14.3. Products
           11.14.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Product (USD MN)
  •  Albumin Market Sales by Geography (USD MN)
  •  Immunoglobulins Market Sales by Geography (USD MN)
  •  Coagulation Factor Concentrates Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis Market by Application (USD MN)
  •  Neurology Market Sales by Geography (USD MN)
  •  Hematology Market Sales by Geography (USD MN)
  •  Immunology Market Sales by Geography (USD MN)
  •  Critical Care Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Analysis by End-User (USD MN)
  •  Hospitals And Clinics Market Sales by Geography (USD MN)
  •  Clinical Research Laboratories Market Sales by Geography (USD MN)
  •  Academic Institutes Market Sales by Geography (USD MN)
  •  Global Plasma Fractionation Market Sales by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisition
 
 LIST OF FIGURES
 
  •  Research Scope of Plasma Fractionation Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Plasma Fractionation Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Product
  •  Market Attractiveness Analysis by Application
  •  Market Attractiveness Analysis by End-User
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Product (USD MN)
  •  Albumin Market Sales by Geography (USD MN)
  •  Immunoglobulins Market Sales by Geography (USD MN)
  •  Coagulation Factor Concentrates Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by Application (USD MN)
  •  Neurology Market Sales by Geography (USD MN)
  •  Hematology Market Sales by Geography (USD MN)
  •  Immunology Market Sales by Geography (USD MN)
  •  Critical Care Market Sales by Geography (USD MN)
  •  Others Market Sales by Geography (USD MN)
  •  Global Market Analysis by End-User (USD MN)
  •  Hospitals And Clinics Market Sales by Geography (USD MN)
  •  Clinical Research Laboratories Market Sales by Geography (USD MN)
  •  Academic Institutes Market Sales by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Top Company Share Analysis
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
After Sales Support
24/7 Email Support

Clients

Testimonials